| Factor Information | |
|---|---|
| Data ID | 571 |
| Factor | longer procedures |
| Description | Thirteen patients died after a cardiac catheterization; they were younger and had longer procedures compared to those who survived (p=0.0001). |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | died after a cardiac catheterization |
| p Value | 0.0001 |
| Conclusion | The most frequent adverse events in general are vascular complications, whereas events related to anesthesia and airway management seem to be among the most frequent major complications. Cardiac interventions, especially balloon dilatation procedures, catheterizations in cyanotic patients or newborns carry the highest risk. Awareness of complications, improved intensive care, improvement in technique and equipment will decrease or avoid the incidence of complications |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 470 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | MID, superior inferior ventricles, PA, VSD, ASD/AVSD, CoA, PDA/TAPVC/PDA, PFO, PDA/TGA/HLHS/HLHS, PDA, CoA/other |
| Reference | |
|---|---|
| PMID | 13653204 |
| Year | 2018 |
| Title | Complications of cardiac catheterization in children with congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | Newborn (1-30days) Infant (1 month-1 year) Child (1-12 years) Adolescent (12-21 years) | |
| Source | Data | |
| Region | İstanbul, Turkey | |
| Method | retrospectively study | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | cardiac catheterizations | |
| Group | deceased patients(Treatment) | patients alive(Control) |
| Number | 13 | 928 |
| Age | 11±23months, median: 0.8 months (age of deceased patients) | 60.6±75.9 months, median 28 months (age of patients alive) |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | procedures: 77.5±31.8 minutes, median: 78 minutes | procedures:45.2±22.9 minutes, median 40 minutes |
